Kaiser Permanente Building, Coolcaesar, Wikimedia Commons, CC BY-3.0

Kaiser Permanente: Living Longer and Better After Cancer

Originally published on KaiserPermanente.org.

Clinical trials play a vital role in advancing cancer treatment at Kaiser Permanente, improving patients’ survival and quality of life.

Clinical trials investigator Helen Moon, MD, is an oncologist-hematologist at Kaiser Permanente’s Riverside Medical Center.

“Until the day that cancer is cured, there’s always room for improvement,” said hematologist-oncologist Helen Moon, MD.

Striving to achieve that improvement is Dr. Moon’s role as a cancer clinical trials investigator for Kaiser Permanente in Southern California. “Clinical trials assess the standard of care versus the new drugs that are coming down the pipeline,” she explained. “We [evaluate] the newest drugs and improve our patients’ survival.”

One of the most promising new approaches to cancer treatment is immunotherapy, which helps a patient’s immune system fight cancer.

“What we are trying to do conceptually is to mount an immune response against that cancer, so not only does the primary cancer shrink, but you’re left with a memory of that cancer immunologically, and it can guard you against further incidents,” said Dr. Moon. “Immunotherapy has really changed the world for a number of cancer patients.”

Learn how research at Kaiser Permanente is transforming health and health care.

Latest News

Video: How Companies Are Ensuring Equity for People With Disabilities

The National Organization on Disability held its annual forum in Washington, D.C. last week, bringing together community leaders, advocates, government officials and corporate leaders and influencers to focus on the advancement of people with disabilities in the workplace. DiversityInc also met up with leaders from Capital One Financial (No. 22…

Validated Allies wallpaper

DiversityInc Announces 2022 Validated Allies

Allyship is a journey rather than a destination. The work of an ally never really ends and allies understand they are not necessarily always working toward a goal, but rather, serving a greater purpose. Each year, as part of our Women of Color and Their Allies event, DiversityInc recognizes a…

CDO Series: Sysco’s Adrienne Trimble

Following the murder of George Floyd, the role of Chief Diversity Officers has become more important as companies started to be more intentional with their diversity, equity and inclusion efforts, which has made the last few years tumultuous for many CDOs. In the latest installment of a series of articles…

NOD Forum: Honoring the Disability Rights Movement

The road to disability rights has been a long one. One that started long before the Americans with Disabilities Act (ADA) of 1990 was passed. In celebration of 40 years of the National Organization on Disability, disability leaders, supporters and activists gathered in Washington, D.C last week to discuss the…

5 Biggest News Stories of the Week: September 29

As the saying goes, the news never stops — but there’s a lot of it out there, and all of it doesn’t always pertain to our readers. In this weekly news roundup, we’ll cover the top news stories that matter most to our diversity focused audience. 1. Research Outlines Lack…

Humana Ranks Highly in the Hispanic Association on Corporate Responsibility Inclusion Index

Originally published at press.humana.com. Humana ranked No. 9 on The DiversityInc Top 50 Companies for Diversity list in 2022.   Humana Inc. celebrates the high rankings it recently received in the 2022 Hispanic Association on Corporate Responsibility (HACR) Corporate Inclusion Index (CII), a research initiative that measures Hispanic inclusion in the…